The best place for the Latest Cardiac and Vascular News
VANCOUVER and MINNEAPOLIS, April 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), today announced that the Tiara Transapical system (“Tiara TA”) will be unable to receive a European CE mark under the current Medical Device Directive regulations (“MDD”) ending on May 26, 2021. The Company is […]
MINNEAPOLIS, April 16, 2021 /PRNewswire/ — Seigla Medical, Inc., announced conformité européenne (CE) Mark for the company’s LiquID™ Guide Catheter Extension for use in coronary and peripheral vasculature interventions. Guide catheter extensions are a crucial tool used by cardiologists worldwide to assist in the delivery of stents and other interventional devices. In addition, […]
Study evaluates safety and performance of endovascular pulmonary neuromodulation in ADHF MINNEAPOLIS, April 15, 2021 /PRNewswire/ — Cardionomic, Inc., a Minneapolis medical device company, is pleased to announce initial enrollment in their Cardionomic Pulmonary Neuromodulation System (CPNS) Pilot Study. The study will evaluate the safety and performance of the CPNS in patients suffering from Acute […]
BRIDGEWATER, N.J., April 15, 2021 /PRNewswire/ — Nipro Medical Corporation (NMC), a leading Renal, Medical, Surgical, and Interventional Radiology products manufacturer, announces the creation of a Vascular Division in the U.S. The division will include several cutting-edge technologies, innovative vascular and cardiovascular products to provide clinicians with procedural and imaging solutions that […]
SUNNYVALE, Calif., April 15, 2021 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the appointment of William Hill as General Counsel. The veteran corporate executive joins the company to oversee all risk management and legal […]
Remote patient monitoring and cardiac data management solution provider is one of only six innovators accepted into the Batch 5 program for Spring 2021 BOSTON, April 15, 2021 /PRNewswire/ — Implicity, a leader in remote patient monitoring and cardiac data management solutions, today announced the company has been selected to join Plug and Play […]
STOCKHOLM, April 15, 2021 /PRNewswire/ — Mentice AB (STO: MNTC), a leading supplier of high-tech solutions for simulation in the medical sector, with a focus on endovascular procedures, today announced the appointment of Pontus Appelqvist as Vice President and General Manager for Asia Pacific. Pontus has more than 20 years of enterprise leadership experience in driving new […]
TEL AVIV, Israel, April 14, 2021 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR, NSPR.WS, NSPR.WSB), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced a 1-for-15 reverse split of its common stock, effective as […]
Silence Therapeutics Announces Publication in Cardiovascular Research Highlighting the Emerging Potential of RNA Therapeutics in Preventing Lipoprotein(a)-Mediated Cardiovascular Disease –High Lipoprotein(a) is a genetically determined cardiovascular risk factor affecting around 20% of the world’s population 15 April 2021 LONDON, Silence Therapeutics plc, AIM:SLN and Nasdaq: SLN (“Silence” or “the Company”), […]
NAPLES, Fla., April 14, 2021 (GLOBE NEWSWIRE) — NCH Healthcare System (NCH) announced that Dr. Robert J. Cubeddu has joined the organization as its new President of the NCH Heart Institute. This is part of NCH’s strategy and commitment to transform its cardiovascular services into a premier destination center for […]
Two seasoned MedTech sales executives join the Company to lead regional rollouts of the PURE EP System (TM), an electrophysiology system for arrhythmia procedures Westport, CT, April 15, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing […]
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ:ABMD) announced today that the first patient has been enrolled in PROTECT IV, a large, prospective, multi-center randomized controlled trial (RCT) that is designed to provide the level of clinical evidence needed to achieve a Class I guideline recommendation for Impella in high-risk percutaneous coronary intervention (HRPCI). The first patient […]
ArtFun+, AI and predictive biomarker software for cardiology LABEL, algorithmic solution for automatic classification and enhancement of medical imaging data PARIS–(BUSINESS WIRE)–IMAGEENS, a Paris-based medical Artificial Intelligence (AI) startup developing software solutions for the analysis of medical images, has secured 1.2Mn€ in seed financing. The round was led by Anaxago, with a […]
